Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
new option listings and fifteen option delistings on August 18th » 08:30
08/18/21
08/18
08:30
08/18/21
08:30
AZRE

Azure Power

$21.02 /

-1.66 (-7.32%)

, BVS

Bioventus

$14.00 /

-0.25 (-1.75%)

, CGEM

Cullinan

$28.35 /

+1.28 (+4.73%)

, DSP

Viant

$14.71 /

+ (+0.00%)

, ELA

Envela

$4.16 /

-0.19 (-4.37%)

, FBMS

First Bancshares

$38.34 /

-1.205 (-3.05%)

, FXLV

F45 Training

$13.56 /

-1.82 (-11.83%)

, GBIL

Goldman Sachs TreasuryAccess 0-1 Year ETF

$100.10 /

-0.005 (-0.00%)

, IMRA

Imara

$4.28 /

+0.07 (+1.66%)

, MIRM

Mirum Pharmaceuticals

$14.41 /

+0.26 (+1.84%)

, NEWP

New Pacific Metals

$3.33 /

-0.185 (-5.26%)

, NTB

N.T. Butterfield

$33.57 /

-0.93 (-2.70%)

, ONTF

On24

$20.78 /

-0.28 (-1.33%)

, PYPD

PolyPid

$7.90 /

-0.3 (-3.66%)

, QIPT

Quipt Home Medical

$5.82 /

-0.04 (-0.68%)

, QUBT

Quantum Computing

$6.33 /

-0.39 (-5.80%)

, SKYT

SkyWater Technology

$19.82 /

-3.17 (-13.79%)

, SLI

Standard Lithium

$5.85 /

-0.96 (-14.10%)

, SOLY

Soliton

$20.64 /

+0.165 (+0.81%)

, TRIN

Trinity Capital

$14.83 /

-0.24 (-1.59%)

, XBIO

Xenetic

$2.95 /

-0.295 (-9.10%)

, CFAC

CF Finance Acquisition Corp. III

/

+

, PTE

PolarityTE

/

+

New option listings for…

New option listings for August 18th include Azure Power (AZRE), Global X Health and Wellness Thematic (BFIT), Bioventus Inc (Class A Stock) (BVS), Pacer US Small Cap Cash Cows 100 (CALF), Cullinan Oncology Inc (CGEM), iShares CMBS (CMBS), iShares California AMT Free Muni Bond (CMF), Dimensional International Core Equity Market ETF (DFAI), Viant Technology Inc (Class A Stock) (DSP), Envela Corporation (ELA), First Bancshares (FBMS), Franklin FTSE China ETF (FLCH), F45 Training Holdings Inc (FXLV), Goldman Sachs Treasuryaccess 0 1 Year ETF (GBIL), Xtrackers International Real Estate ETF (HAUZ), iShares (HEEM), WisdomTree BofA Merrill Lynch High Yield Bond Zero Duration Fund (HYZD), Invesco Nasdaq Biotechnology ETF (IBBQ), Proshares Investment Grade Interest Rate Hedged (IGHG), IMARA Inc (IMRA), Kraneshares Cicc China Consumer Leaders Index ETF (KBUY), KraneShares Emerging Mkts Consumer Technology Idx ETF (KEMQ), AEye Inc (Class A Stock) (LIDR), iShares Inflation Hedged Corporate Bond ETF (LQDI), Legg Mason Low Volatility High Dividend (LVHD), Mirum Pharmaceuticals Inc (MIRM), New Pacific Metals Corporation (NEWP), Butterfield (NTB), ON24 Inc (ONTF), PolyPid Ltd (PYPD), Quipt Home Medical Corporation (QIPT), HCM Defender 100 Index ETF (QQH), Quantum Computing Inc (QUBT), SkyWater Technology Inc (SKYT), Standard Lithium Ltd (SLI), Soliton Inc (SOLY), Invesco PHLX Semiconductor ETF (SOXQ), Global X SuperIncome Preferred (SPFF), SPDR Portfolio High Yield Bond ETF (SPHY), PIMCO 1 to 5 Year US TIPS Index ETF (STPZ), iShares Trust iShares ESG Aware 1 to 5 Year USD Corporate Bond (SUSB), Motley Fool 100 Index ETF (TMFC), Trinity Capital Inc (TRIN), United States Commodity Index Fund (USCI), and Xenetic Biosciences (XBIO). Option delistings effective August 18th include Test (ATEST), Test (CBO), CF Finance Acquisition Corporation III (CFAC), CTEST Stock (CTEST), MTEST Stock (MTEST), NYSE Tick Pilot TEST (NTEST), Test (PTEST), TEST (ZAZZT), BATS Test (ZBZX), Test (ZJZZT), TEST (ZVZZT), TEST (ZWZZT), TEST (ZXZZT), Test (ZZK), and Test (ZZZ).

ShowHide Related Items >><<
SOLY Soliton
$20.64 /

+0.165 (+0.81%)

SLI Standard Lithium
$5.85 /

-0.96 (-14.10%)

SKYT SkyWater Technology
$19.82 /

-3.17 (-13.79%)

QUBT Quantum Computing
$6.33 /

-0.39 (-5.80%)

QIPT Quipt Home Medical
$5.82 /

-0.04 (-0.68%)

PYPD PolyPid
$7.90 /

-0.3 (-3.66%)

PTE PolarityTE
/

+

ONTF On24
$20.78 /

-0.28 (-1.33%)

NTB N.T. Butterfield
$33.57 /

-0.93 (-2.70%)

NEWP New Pacific Metals
$3.33 /

-0.185 (-5.26%)

MIRM Mirum Pharmaceuticals
$14.41 /

+0.26 (+1.84%)

IMRA Imara
$4.28 /

+0.07 (+1.66%)

FXLV F45 Training
$13.56 /

-1.82 (-11.83%)

FBMS First Bancshares
$38.34 /

-1.205 (-3.05%)

ELA Envela
$4.16 /

-0.19 (-4.37%)

DSP Viant
$14.71 /

+ (+0.00%)

CGEM Cullinan
$28.35 /

+1.28 (+4.73%)

CFAC CF Finance Acquisition Corp. III
/

+

BVS Bioventus
$14.00 /

-0.25 (-1.75%)

AZRE Azure Power
$21.02 /

-1.66 (-7.32%)

AZRE Azure Power
$21.02 /

-1.66 (-7.32%)

06/17/21 Barclays
Azure Power price target lowered to $37 from $45 at Barclays
04/06/21 RBC Capital
RBC starts India solar power play Azure Power at Outperform
04/06/21 RBC Capital
Azure Power initiated with an Outperform at RBC Capital
02/16/21 Barclays
Azure Power price target raised to $45 from $35 at Barclays
BVS Bioventus
$14.00 /

-0.25 (-1.75%)

08/02/21 BTIG
Misonix downgraded to Neutral from Buy at BTIG
07/30/21 Craig-Hallum
Misonix downgraded to Hold from Buy at Craig-Hallum
07/01/21
Fly Intel: Top five analyst downgrades
07/01/21 Goldman Sachs
Bioventus downgraded to Neutral from Buy at Goldman Sachs
CGEM Cullinan
$28.35 /

+1.28 (+4.73%)

06/04/21 H.C. Wainwright
Cullinan price target raised to $55 at H.C. Wainwright after 'impressive' data
04/27/21
Fly Intel: Top five analyst upgrades
04/27/21 Morgan Stanley
Cullinan upgraded to Overweight ahead of CLN-081 data at Morgan Stanley
04/27/21 Morgan Stanley
Cullinan upgraded to Overweight from Equal Weight at Morgan Stanley
DSP Viant
$14.71 /

+ (+0.00%)

08/13/21 Canaccord
Viant price target lowered to $38 from $48 at Canaccord
07/30/21 BofA
Viant upgraded to Buy from Neutral at BofA
07/30/21 BofA
Viant upgraded to Buy from Neutral at BofA
05/14/21 Canaccord
Viant price target lowered to $48 from $65 at Canaccord
ELA Envela
$4.16 /

-0.19 (-4.37%)

07/28/21
Fly Intel: Top five analyst initiations
07/28/21 Lake Street
Envela initiated with a Buy at Lake Street
03/09/21
Fly Intel: Top five analyst initiations
03/09/21 B. Riley
B. Riley sees 100% upside in Envela, starts with Buy rating
FBMS First Bancshares
$38.34 /

-1.205 (-3.05%)

06/14/21
Fly Intel: Top five analyst downgrades
06/14/21 DA Davidson
First Bancshares downgraded to Neutral from Buy at DA Davidson
06/07/21 Hovde Group
First Bancshares initiated with a Market Perform at Hovde Group
FXLV F45 Training
$13.56 /

-1.82 (-11.83%)

08/09/21
Fly Intel: Top five analyst initiations
08/09/21 Cowen
Cowen sees boutique fitness, starts F45 Training with Outperform
08/09/21 JPMorgan
JPMorgan starts F45 Training at Neutral, sees U.S. targets as 'aggressive'
08/09/21 Roth Capital
F45 Training initiated with a Buy at Roth Capital
GBIL Goldman Sachs TreasuryAccess 0-1 Year ETF
$100.10 /

-0.005 (-0.00%)

IMRA Imara
$4.28 /

+0.07 (+1.66%)

08/11/21 Morgan Stanley
Imara downgraded to Equal Weight from Overweight at Morgan Stanley
08/11/21 Morgan Stanley
Imara downgraded to Equal Weight from Overweight at Morgan Stanley
03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
MIRM Mirum Pharmaceuticals
$14.41 /

+0.26 (+1.84%)

03/29/21 Piper Sandler
Piper says Mirum approval for Alagille syndrome 'in the bag'
02/08/21 SVB Leerink
Mirum Pharmaceuticals initiated with an Outperform at SVB Leerink
02/01/21 Piper Sandler
Piper says FDA 'very unlikely' to require AdCom for Mirum's maralixibat in ALGS
12/09/20 Piper Sandler
Mirum Pharmaceuticals investor day highlights pipeline advances, says Piper
NEWP New Pacific Metals
$3.33 /

-0.185 (-5.26%)

NTB N.T. Butterfield
$33.57 /

-0.93 (-2.70%)

04/14/21 Citi
N.T. Butterfield price target raised to $39 from $35 at Citi
02/12/21 Citi
N.T. Butterfield price target raised to $35 from $31 at Citi
10/08/20 Goldman Sachs
N.T. Butterfield assumed with a Buy from Neutral at Goldman Sachs
ONTF On24
$20.78 /

-0.28 (-1.33%)

08/11/21 Canaccord
Canaccord downgrades On24, lack of cataalysts seen
08/11/21 KeyBanc
On24 price target lowered to $40 from $57 at KeyBanc
08/11/21 JPMorgan
JPMorgan downgrades On24 to Neutral on worse than expected churn
08/11/21 Baird
On24 price target lowered to $38 from $70 at Baird
PYPD PolyPid
$7.90 /

-0.3 (-3.66%)

07/30/21
Fly Intel: Top five analyst initiations
07/30/21 Cantor Fitzgerald
PolyPid initiated with an Overweight at Cantor Fitzgerald
07/30/21 Cantor Fitzgerald
PolyPid initiated with an Overweight at Cantor Fitzgerald
11/24/20 Raymond James
Raymond James upgrades PolyPid to Strong Buy after BTD for D-PLEX
QIPT Quipt Home Medical
$5.82 /

-0.04 (-0.68%)

QUBT Quantum Computing
$6.33 /

-0.39 (-5.80%)

SKYT SkyWater Technology
$19.82 /

-3.17 (-13.79%)

08/05/21 Jefferies
SkyWater Technology downgraded to Hold from Buy at Jefferies
07/16/21 Needham
SkyWater Technology initiated with a Buy at Needham
05/17/21 Jefferies
SkyWater Technology initiated with a Buy at Jefferies
05/17/21 Piper Sandler
SkyWater Technology initiated with an Overweight at Piper Sandler
SLI Standard Lithium
$5.85 /

-0.96 (-14.10%)

08/12/21 Canaccord
Standard Lithium downgraded to Hold from Speculative Buy at Canaccord
07/16/21 Roth Capital
Standard Lithium price target raised to $6.50 from $3.77 at Roth Capital
SOLY Soliton
$20.64 /

+0.165 (+0.81%)

06/02/21 Roth Capital
Soliton downgraded to Neutral from Buy at Roth Capital
05/13/21
Fly Intel: Top five analyst downgrades
05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
TRIN Trinity Capital
$14.83 /

-0.24 (-1.59%)

05/07/21 Ladenburg
Ladenburg upgrades Trinity Capital to Buy, sees 24% total return
05/07/21 Ladenburg
Trinity Capital upgraded to Buy from Neutral at Ladenburg
05/03/21 Oppenheimer
Trinity Capital initiated with an Outperform at Oppenheimer
02/23/21 B. Riley
B. Riley starts Trinity Capital at Buy, sees total return of 20%
XBIO Xenetic
$2.95 /

-0.295 (-9.10%)

01/11/21 H.C. Wainwright
Xenetic price target raised to $5 from $2 at H.C. Wainwright
CFAC CF Finance Acquisition Corp. III
/

+

PTE PolarityTE
/

+

11/19/20 Cantor Fitzgerald
PolarityTE patent status change removes key overhang, says Cantor Fitzgerald
TRIN Trinity Capital
$14.83 /

-0.24 (-1.59%)

SOLY Soliton
$20.64 /

+0.165 (+0.81%)

SKYT SkyWater Technology
$19.82 /

-3.17 (-13.79%)

QIPT Quipt Home Medical
$5.82 /

-0.04 (-0.68%)

PYPD PolyPid
$7.90 /

-0.3 (-3.66%)

PTE PolarityTE
/

+

ONTF On24
$20.78 /

-0.28 (-1.33%)

NTB N.T. Butterfield
$33.57 /

-0.93 (-2.70%)

MIRM Mirum Pharmaceuticals
$14.41 /

+0.26 (+1.84%)

IMRA Imara
$4.28 /

+0.07 (+1.66%)

FBMS First Bancshares
$38.34 /

-1.205 (-3.05%)

DSP Viant
$14.71 /

+ (+0.00%)

CGEM Cullinan
$28.35 /

+1.28 (+4.73%)

BVS Bioventus
$14.00 /

-0.25 (-1.75%)

AZRE Azure Power
$21.02 /

-1.66 (-7.32%)

  • 14
    Jul
  • 15
    Jul
  • 21
    Apr
  • 11
    Feb
  • 10
    Feb
  • 03
    Feb
  • 29
    Jan
  • 08
    Jan
  • 15
    Dec
SOLY Soliton
$20.64 /

+0.165 (+0.81%)

SKYT SkyWater Technology
$19.82 /

-3.17 (-13.79%)

PTE PolarityTE
/

+

ONTF On24
$20.78 /

-0.28 (-1.33%)

IMRA Imara
$4.28 /

+0.07 (+1.66%)

FXLV F45 Training
$13.56 /

-1.82 (-11.83%)

DSP Viant
$14.71 /

+ (+0.00%)

CFAC CF Finance Acquisition Corp. III
/

+

Initiation
Fly Intel: Top five analyst initiations » 09:54
07/28/21
07/28
09:54
07/28/21
09:54
NYXH

Nyxoah

$33.02 /

+0.22 (+0.67%)

, SKLZ

Skillz

$14.27 /

+ (+0.00%)

, MSFT

Microsoft

$284.90 /

-1.99 (-0.69%)

, KRTX

Karuna Therapeutics

$115.00 /

+4.09 (+3.69%)

, ELA

Envela

$4.12 /

+0.09 (+2.23%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Nyxoah (NYXH) initiated with an Overweight at Cantor Fitzgerald and Piper Sandler. 2. Skillz (SKLZ) initiated with a Sector Perform at RBC Capital. 3. Microsoft (MSFT) assumed with an Outperform at RBC Capital. 4. Karuna Therapeutics (KRTX) initiated with a Buy at Jefferies. 5. Envela (ELA) initiated with a Buy at Lake Street. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
SKLZ Skillz
$14.27 /

+ (+0.00%)

MSFT Microsoft
$284.90 /

-1.99 (-0.69%)

KRTX Karuna Therapeutics
$115.00 /

+4.09 (+3.69%)

ELA Envela
$4.12 /

+0.09 (+2.23%)

NYXH Nyxoah
$33.02 /

+0.22 (+0.67%)

07/28/21 Cantor Fitzgerald
Nyxoah initiated with an Overweight at Cantor Fitzgerald
07/28/21 Cantor Fitzgerald
Nyxoah initiated with an Overweight at Cantor Fitzgerald
07/28/21 Piper Sandler
Nyxoah initiated with an Overweight at Piper Sandler
07/27/21
Fly Intel: Top five analyst initiations
SKLZ Skillz
$14.27 /

+ (+0.00%)

07/28/21 RBC Capital
Skillz initiated with a Sector Perform at RBC Capital
05/21/21 Citi
Skillz price target lowered to $23 from $27 at Citi
05/06/21 Wells Fargo
Skillz price target lowered to $18.50 from $28 at Wells Fargo
05/05/21 Canaccord
Skillz price target lowered to $30 from $33 at Canaccord
MSFT Microsoft
$284.90 /

-1.99 (-0.69%)

07/28/21 BMO Capital
Microsoft price target raised to $325 from $290 at BMO Capital
07/28/21 Wedbush
Wedbush bullish on Microsoft following 'robust' results, guidance
07/28/21 Credit Suisse
Microsoft price target raised to $320 from $300 at Credit Suisse
07/28/21 Stifel
Microsoft price target raised to $325 from $305 at Stifel
KRTX Karuna Therapeutics
$115.00 /

+4.09 (+3.69%)

07/28/21 Jefferies
Karuna Therapeutics initiated with a Buy at Jefferies
06/30/21 Citi
Karuna Therapeutics selloff brings buying opportunity, says Citi
06/30/21 Mizuho
Karuna selloff on Cerevel data 'appears overdone,' says Mizuho
06/23/21 William Blair
William Blair says Karuna DRP data show KarXT's 'pipeline in a drug potential'
ELA Envela
$4.12 /

+0.09 (+2.23%)

07/28/21 Lake Street
Envela initiated with a Buy at Lake Street
03/09/21
Fly Intel: Top five analyst initiations
03/09/21 B. Riley
B. Riley sees 100% upside in Envela, starts with Buy rating
03/09/21 B. Riley
Envela initiated with a Buy at B. Riley Securities
SKLZ Skillz
$14.27 /

+ (+0.00%)

MSFT Microsoft
$284.90 /

-1.99 (-0.69%)

KRTX Karuna Therapeutics
$115.00 /

+4.09 (+3.69%)

  • 19
    Mar
  • 02
    Mar
SKLZ Skillz
$14.27 /

+ (+0.00%)

MSFT Microsoft
$284.90 /

-1.99 (-0.69%)

SKLZ Skillz
$14.27 /

+ (+0.00%)

MSFT Microsoft
$284.90 /

-1.99 (-0.69%)

SKLZ Skillz
$14.27 /

+ (+0.00%)

MSFT Microsoft
$284.90 /

-1.99 (-0.69%)

Initiation
Envela initiated with a Buy at Lake Street » 08:51
07/28/21
07/28
08:51
07/28/21
08:51
ELA

Envela

$4.03 /

+0.24 (+6.33%)

Lake Street analyst Mark…

Lake Street analyst Mark Argento initiated coverage of Envela with a Buy rating and $10 price target, calling the company "an under-the-radar provider of recommerce and recycling services" that help organizations meet environmental, social, and governance, or ESG, and return-on-investment, or ROI, initiatives. Envela CEO John Loftus, who owns 70% of the company, has "piloted the company through an impressive turnaround," Argento contends.

ShowHide Related Items >><<
ELA Envela
$4.03 /

+0.24 (+6.33%)

ELA Envela
$4.03 /

+0.24 (+6.33%)

03/09/21
Fly Intel: Top five analyst initiations
03/09/21 B. Riley
B. Riley sees 100% upside in Envela, starts with Buy rating
03/09/21 B. Riley
Envela initiated with a Buy at B. Riley Securities
Over a quarter ago
Hot Stocks
Envela expands electronics-trade-In capabilities with acquisition » 09:07
06/10/21
06/10
09:07
06/10/21
09:07
ELA

Envela

$5.56 /

+0.21 (+3.93%)

Envela announced that…

Envela announced that its subsidiary CEX Holdings, has purchased the assets of CExchange a leader in electronics-trade-in services for retailers. Envela believes this acquisition will bring promising synergies of cost reductions and efficiencies, and contribute to revenue and earnings accretion to shareholders. It also advances the Company's ongoing strategy to expand its presence in the environmentally friendly recommerce sector.

ShowHide Related Items >><<
ELA Envela
$5.56 /

+0.21 (+3.93%)

03/09/21
Fly Intel: Top five analyst initiations
03/09/21 B. Riley
B. Riley sees 100% upside in Envela, starts with Buy rating
03/09/21 B. Riley
Envela initiated with a Buy at B. Riley Securities
Initiation
Fly Intel: Top five analyst initiations » 09:53
03/09/21
03/09
09:53
03/09/21
09:53
SLDB

Solid Biosciences

$10.50 /

+0.98 (+10.29%)

, HIMS

Hims & Hers

$13.65 /

+0.7 (+5.41%)

, THBR

Thunder Bridge Acquisition II

$10.60 /

+0.23 (+2.22%)

, BBY

Best Buy

$106.68 /

-0.07 (-0.07%)

, ELA

Envela

$5.07 /

+0.36 (+7.64%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Solid Biosciences (SLDB) initiated with an Overweight at Barclays. 2. Hims & Hers (HIMS) initiated with a Neutral at Credit Suisse. 3. Thunder Bridge Acquisition II (THBR) initiated with a Buy at Benchmark. 4. Best Buy (BBY) initiated with a Sell at Citi. 5. Envela (ELA) initiated with a Buy at B. Riley Securities. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
THBR Thunder Bridge Acquisition II
$10.60 /

+0.23 (+2.22%)

SLDB Solid Biosciences
$10.50 /

+0.98 (+10.29%)

HIMS Hims & Hers
$13.65 /

+0.7 (+5.41%)

BBY Best Buy
$106.68 /

-0.07 (-0.07%)

SLDB Solid Biosciences
$10.50 /

+0.98 (+10.29%)

03/09/21 Barclays
Solid Biosciences initiated with an Overweight at Barclays
01/08/21 Chardan
Solid Biosciences selloff on Sarepta news a buying opportunity, says Chardan
01/08/21 Credit Suisse
Solid Biosciences upgraded to Neutral on Sarepta setback at Credit Suisse
01/08/21 Credit Suisse
Solid Biosciences upgraded to Neutral from Underperform at Credit Suisse
HIMS Hims & Hers
$13.65 /

+0.7 (+5.41%)

03/09/21 Credit Suisse
Hims & Hers initiated with a Neutral at Credit Suisse
03/03/21 Piper Sandler
Cigna acquisition 'incremental negative' for Hims & Hers, says Piper Sandler
03/02/21 Citi
Hims & Hers upgraded to Buy from Neutral at Citi
03/02/21 Citi
Hims & Hers upgraded to Buy from Neutral at Citi
THBR Thunder Bridge Acquisition II
$10.60 /

+0.23 (+2.22%)

03/09/21 Benchmark
Thunder Bridge Acquisition II initiated with a Buy at Benchmark
BBY Best Buy
$106.68 /

-0.07 (-0.07%)

03/09/21 Citi
Citi starts Best Buy with Sell, sees 'too many red flags'
03/08/21 Citi
Best Buy initiated with a Sell at Citi
03/04/21 Loop Capital
Best Buy to be 'major beneficiary' of Fry liquidation, says Loop Capital
02/26/21
Fly Intel: Top five analyst downgrades
ELA Envela
$5.07 /

+0.36 (+7.64%)

03/09/21 B. Riley
B. Riley sees 100% upside in Envela, starts with Buy rating
03/09/21 B. Riley
Envela initiated with a Buy at B. Riley Securities
SLDB Solid Biosciences
$10.50 /

+0.98 (+10.29%)

BBY Best Buy
$106.68 /

-0.07 (-0.07%)

HIMS Hims & Hers
$13.65 /

+0.7 (+5.41%)

BBY Best Buy
$106.68 /

-0.07 (-0.07%)

SLDB Solid Biosciences
$10.50 /

+0.98 (+10.29%)

BBY Best Buy
$106.68 /

-0.07 (-0.07%)

THBR Thunder Bridge Acquisition II
$10.60 /

+0.23 (+2.22%)

HIMS Hims & Hers
$13.65 /

+0.7 (+5.41%)

BBY Best Buy
$106.68 /

-0.07 (-0.07%)

Initiation
B. Riley sees 100% upside in Envela, starts with Buy rating » 07:53
03/09/21
03/09
07:53
03/09/21
07:53
ELA

Envela

$4.71 /

-0.17 (-3.48%)

B. Riley Securities…

B. Riley Securities analyst Jeff Van Sinderen initiated coverage of Envela with a Buy rating and $10 price target, which represents 100% upside from current share levels. The company's ECHG segment provides electronics reuse and recycling and represents higher growth potential than the legacy business, driven by accelerating sustainability trends and the rapidly increasing supply of used electronic products, Van Sinderen tells investors in a research note. Although the ECHG segment is relatively young, its customers include Verizon, Samsung, AT&T, Comcast, Tesla, Microsoft, and Amazon, says the analyst.

ShowHide Related Items >><<
ELA Envela
$4.71 /

-0.17 (-3.48%)

03/09/21 B. Riley
Envela initiated with a Buy at B. Riley Securities
Initiation
Envela initiated with a Buy at B. Riley Securities » 05:19
03/09/21
03/09
05:19
03/09/21
05:19
ELA

Envela

$4.71 /

-0.17 (-3.48%)

B. Riley Securities…

B. Riley Securities initiated coverage of Envela with a Buy rating and $10 price target.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.